Dr Zhiping Li is responsible for the strategic business planning and management of IHH’s operations and facilities in China. Apart from hospital and clinic operations, he also oversees the corporate, governance and control functions of the China corporate office.

A healthcare veteran with over 30 years of experience in the United States and Chinese healthcare industry, Dr Li has assumed diverse roles and risen through the ranks across his career. His past employers include the University of North Carolina at Chapel Hill, North Carolina, John Hopkins Medicine in Baltimore, Maryland, and most recently Taikang Xianlin Drum Tower Hospital in Nanjing, China, where he served as President

Academic/Professional Qualification(s)

  • Bachelor of Medicine & Surgery, Shanghai Second Medical University, China
  • Residency, Case Western Reserve University, Cleveland, Ohio, USA
  • Fellowship, Johns Hopkins Medicine, Baltimore, Maryland, USA



  • Does not have any family relationships with any directors and / or major shareholders of the Company.
  • Does not have any conflict of interest with the Company.
  • Does not have any convictions for offences within the past five years other than for traffic offences, if any.
Dr Zhiping Li

Dr Zhiping Li

Chief Executive Officer,
IHH Healthcare China

Nationality: American
Gender: Male
Age: 58 (As at 5 April 2024)
Date of Appointment: 26 October 2020